I see that ACST has been rolling in correlation with the broader market. The biopharma space had some positive sentiment and I think that drove most of the volume we have seen. The S&P looks like its forming a reversal slightly ahead of ACST. Not really anything wildly groundbreaking about that analysis but maybe a light at the end of the tunnel for some bulls.
Comment:
Pretty solid correlation with the S&P ACST rallying right along. Can the S&P provide advanced warning of the top if it continues to correlate? It could but worth remembering that correlation does not equal causation, stay frosty.